These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 11034370)

  • 21. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
    J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
    Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U
    Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xenogeneic human NK cytotoxicity against porcine endothelial cells is perforin/granzyme B dependent and not inhibited by Bcl-2 overexpression.
    Matter-Reissmann UB; Forte P; Schneider MK; Filgueira L; Groscurth P; Seebach JD
    Xenotransplantation; 2002 Sep; 9(5):325-37. PubMed ID: 12199864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
    Taylor MA; Ward B; Schatzle JD; Bennett M
    Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FD-891, a structural analogue of concanamycin A that does not affect vacuolar acidification or perforin activity, yet potently prevents cytotoxic T lymphocyte-mediated cytotoxicity through the blockage of conjugate formation.
    Kataoka T; Yamada A; Bando M; Honma T; Mizoue K; Nagai K
    Immunology; 2000 Jun; 100(2):170-7. PubMed ID: 10886392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity.
    Medana I; Li Z; Flügel A; Tschopp J; Wekerle H; Neumann H
    J Immunol; 2001 Jul; 167(2):674-81. PubMed ID: 11441070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases.
    Caldwell SA; Ryan MH; McDuffie E; Abrams SI
    J Immunol; 2003 Sep; 171(5):2402-12. PubMed ID: 12928387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expression.
    Delgado M; Ganea D
    J Immunol; 2000 Jul; 165(1):114-23. PubMed ID: 10861043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential contribution of Fas- and perforin-mediated mechanisms to the cell-mediated cytotoxic activity of naive and in vivo-primed intestinal intraepithelial lymphocytes.
    Corazza N; Müller S; Brunner T; Kägi D; Mueller C
    J Immunol; 2000 Jan; 164(1):398-403. PubMed ID: 10605035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells.
    Roth E; Pircher H
    J Immunol; 2004 Feb; 172(3):1588-94. PubMed ID: 14734739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell death mediated by alloreactive cytotoxic T cells via the granule exocytosis or the Fas pathway is independent of p34cdc2 kinase: Fas dependent killing of cells arrested in the cell cycle.
    Waring P; Müllbacher A
    Immunol Cell Biol; 2001 Jun; 79(3):264-73. PubMed ID: 11380680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
    Williams NS; Engelhard VH
    J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ca2+ signaling modulates cytolytic T lymphocyte effector functions.
    Esser MT; Haverstick DM; Fuller CL; Gullo CA; Braciale VL
    J Exp Med; 1998 Apr; 187(7):1057-67. PubMed ID: 9529322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes.
    Lowin B; Mattman C; Hahne M; Tschopp J
    Int Immunol; 1996 Jan; 8(1):57-63. PubMed ID: 8671589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+ T cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a MHC antigen- and Fas-independent fashion.
    Hombach A; Heuser C; Marquardt T; Wieczarkowiecz A; Groneck V; Pohl C; Abken H
    J Immunol; 2001 Jul; 167(2):1090-6. PubMed ID: 11441120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-mediated cytotoxicity in recovery from poxvirus infections.
    Müllbacher A
    Rev Med Virol; 2003; 13(4):223-32. PubMed ID: 12820184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms.
    Smith DJ; McGuire MJ; Tocci MJ; Thiele DL
    J Immunol; 1997 Jan; 158(1):163-70. PubMed ID: 8977187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a granule-independent lytic mechanism used by CTL hybridomas.
    Garner R; Helgason CD; Atkinson EA; Pinkoski MJ; Ostergaard HL; Sorensen O; Fu A; Lapchak PH; Rabinovitch A; McElhaney JE
    J Immunol; 1994 Dec; 153(12):5413-21. PubMed ID: 7527440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.